The composite of death, MI, and stroke showed a similar pattern between patients with increased and normal copeptin values, in the entire cohort (40.9% vs. 20.6%, p < 0.001) as well as in ACS (40.9% vs. 21.6%, p < 0.001) and non-ACS patients (41.0% vs. 14.3%, p < 0.001). This evidence concerns the gene AVP and Stroke.